Top 10 Losers on Tuesday
The S&P 500 index rose for the second consecutive day, powered by increases in economically sensitive stocks such as commodity producers.
Spero Therapeutics Inc. (SPRO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 939,017 | $696 | +761% | 0% |
| 2. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 770,710 | $571 | -23% | 0.01% |
| 3. | Diametric Capital Nick Thakore | 20,700 | $15 | 0.01% | |
| 4. | Bourgeon Capital John Zaro | 17,600 | $13 | -73% | 0% |
| 5. | Engineers Gate Manager Greg Eisner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.24 | 39,727 | Large Shareholder | 5,321,231 | 2022-04-26 | Filing | |
| $8.79 | 16,885 | Large Shareholder | 5,281,504 | 2022-03-30 | Filing | |
| $8.79 | 33,115 | Large Shareholder | 5,264,619 | 2022-03-30 | Filing | |
| $7.63 | 8,006 | Large Shareholder | 5,231,504 | 2022-03-14 | Filing | |
| $7.63 | 15,702 | Large Shareholder | 5,223,498 | 2022-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.58 | 8,000 | Officer, Director | 144,036 | 2021-12-27 | Filing | |
| $21.74 | 3,000 | Large Shareholder | 3,829,209 | 2021-02-08 | Filing | |
| $18.99 | 34,144 | Large Shareholder | 3,832,209 | 2021-02-04 | Filing | |
| $18.98 | 29,354 | Large Shareholder | 3,866,353 | 2021-02-03 | Filing | |
| $18.99 | 22,841 | Large Shareholder | 3,895,707 | 2021-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 27,176 | $20,137 | 0% | |
| 2. | 1,376,968 | $1,019 | 2.31% | |
| 3. | 1,245,992 | $924 | 0% | |
| 4. | 1,031,160 | $764 | 0.12% | |
| 5. | 690,753 | $513 | 0% |
News See All
Is SPRO A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
Marc Schneidman’s Aquilo Capital Management is a San Francisco-based, healthcare-focused long/short hedge fund that was founded in 2010.
Is Spero Therapeutics, Inc. (SPRO) Going to Burn These Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Here is What Hedge Funds Think About Spero Therapeutics, Inc. (SPRO)
Is Spero Therapeutics, Inc. (NASDAQ:SPRO) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on ...
13G Filing: Biotechnology Value Fund LP and Spero Therapeutics Inc (SPRO)
Spero Therapeutics Inc (NASDAQ:SPRO): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
Billionaire Hedge Funds
